Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

Navigating challenges of MedTech research with rare-disease patients

White Papers and Resources | February 16, 2024 | Inizio

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

Did You Hear From Her? If Not Here’s What You Missed in Season 1 of the Award-Winning Season Podcast Series

Press Releases | February 15, 2024 | Medscape Education

What are some of the biggest gaps that women face in healthcare today?  “So many I could talk for hours!” said Shikha Jain, MD, FACP, President, CEO, Founder Women in Medicine....

Have you heard from her?

Press Releases | February 15, 2024 | Medscape Education

We’re referring to the renowned women leaders from across the healthcare landscape who were our guests on Season 1 of Medscape Education’s Hear From Her podcast series. The conversations touched...

Clinical trial considerations: Why diversity matters…

White Papers and Resources | February 15, 2024 | Cuttsy + Cuttsy

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

Rare Disease Diagnostic Odyssey

Videos and Podcasts | February 14, 2024 | Medscape Education

Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions

Press Releases | February 14, 2024 | Petauri Evidence

Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February, to explore rare disease market access challenges and learn more about these high potential markets.

The pitfalls of cutting costs on systematic literature reviews: 11 common issues to avoid

White Papers and Resources | February 14, 2024 | Petauri Evidence

Embarking on a systematic literature review is a critical step in evidence synthesis, providing a foundation for robust decision-making in the healthcare landscape. As with most things, there are ways...

Product launch: What market research when?

White Papers and Resources | February 14, 2024 | Inizio

Get the insights you need, when you need them, for your product launch planning

Clinical trial considerations: Why digital matters…

White Papers and Resources | February 14, 2024 | Cuttsy + Cuttsy

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

Top-5 Trends in Virtual KOL Engagement

Press Releases | February 12, 2024 | Impetus Digital

Register now for one of our upcoming webinars (February 26-28)